These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31945090)

  • 21. Dissection of a CTCF topological boundary uncovers principles of enhancer-oncogene regulation.
    Kim KL; Rahme GJ; Goel VY; El Farran CA; Hansen AS; Bernstein BE
    Mol Cell; 2024 Apr; 84(7):1365-1376.e7. PubMed ID: 38452764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer.
    Bailey CG; Metierre C; Feng Y; Baidya K; Filippova GN; Loukinov DI; Lobanenkov VV; Semaan C; Rasko JE
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenome editing strategies for the functional annotation of CTCF insulators.
    Tarjan DR; Flavahan WA; Bernstein BE
    Nat Commun; 2019 Sep; 10(1):4258. PubMed ID: 31534142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic landscapes suggest that genetic risk for intracranial aneurysm operates on the endothelium.
    Poppenberg KE; Jiang K; Tso MK; Snyder KV; Siddiqui AH; Kolega J; Jarvis JN; Meng H; Tutino VM
    BMC Med Genomics; 2019 Oct; 12(1):149. PubMed ID: 31666072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of CCCTC-binding factor in epigenetic regulation of cancer.
    Bose S; Saha S; Goswami H; Shanmugam G; Sarkar K
    Mol Biol Rep; 2023 Dec; 50(12):10383-10398. PubMed ID: 37840067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis.
    Recillas-Targa F; De La Rosa-Velázquez IA; Soto-Reyes E; Benítez-Bribiesca L
    J Cell Mol Med; 2006; 10(3):554-68. PubMed ID: 16989720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer.
    Takai D; Gonzales FA; Tsai YC; Thayer MJ; Jones PA
    Hum Mol Genet; 2001 Nov; 10(23):2619-26. PubMed ID: 11726548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.
    Kaiser VB; Taylor MS; Semple CA
    PLoS Genet; 2016 Aug; 12(8):e1006207. PubMed ID: 27490693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTCF Binding Sites in the Herpes Simplex Virus 1 Genome Display Site-Specific CTCF Occupation, Protein Recruitment, and Insulator Function.
    Washington SD; Musarrat F; Ertel MK; Backes GL; Neumann DM
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Mutations Form at CTCF-Cohesin Binding Sites in Melanoma Due to Uneven Nucleotide Excision Repair across the Motif.
    Poulos RC; Thoms JAI; Guan YF; Unnikrishnan A; Pimanda JE; Wong JWH
    Cell Rep; 2016 Dec; 17(11):2865-2872. PubMed ID: 27974201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites.
    Xie X; Mikkelsen TS; Gnirke A; Lindblad-Toh K; Kellis M; Lander ES
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7145-50. PubMed ID: 17442748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity.
    De S; Shaknovich R; Riester M; Elemento O; Geng H; Kormaksson M; Jiang Y; Woolcock B; Johnson N; Polo JM; Cerchietti L; Gascoyne RD; Melnick A; Michor F
    PLoS Genet; 2013; 9(1):e1003137. PubMed ID: 23326238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovering a binary CTCF code with a little help from BORIS.
    Lobanenkov VV; Zentner GE
    Nucleus; 2018 Jan; 9(1):33-41. PubMed ID: 29077515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DeepCBS: shedding light on the impact of mutations occurring at CTCF binding sites.
    Wang Y; Guo X; Niu Z; Huang X; Wang B; Gao L
    Front Genet; 2024; 15():1354208. PubMed ID: 38463168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation-independent removable insulator controls chromatin remodeling at the HOXA locus via retinoic acid signaling.
    Ishihara K; Nakamoto M; Nakao M
    Hum Mol Genet; 2016 Dec; 25(24):5383-5394. PubMed ID: 27798106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research progress of CTCF in mediating 3D genome formation and regulating gene expression.
    Zhou C; Zhou QW; Cheng S; Li GL
    Yi Chuan; 2021 Sep; 43(9):816-821. PubMed ID: 34702695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.
    Jung H; Kim HS; Kim JY; Sun JM; Ahn JS; Ahn MJ; Park K; Esteller M; Lee SH; Choi JK
    Nat Commun; 2019 Sep; 10(1):4278. PubMed ID: 31537801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of cancer mutational signatures on transcription factor motifs in the human genome.
    Yiu Chan CW; Gu Z; Bieg M; Eils R; Herrmann C
    BMC Med Genomics; 2019 May; 12(1):64. PubMed ID: 31109337
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Hori I; Kawamura R; Nakabayashi K; Watanabe H; Higashimoto K; Tomikawa J; Ieda D; Ohashi K; Negishi Y; Hattori A; Sugio Y; Wakui K; Hata K; Soejima H; Kurosawa K; Saitoh S
    J Med Genet; 2017 Dec; 54(12):836-842. PubMed ID: 28848059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.